|
MEIP | Lite Strategy, Inc. |
|
|
MEIP | Lite Strategy, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 8.34 |
| Leverage | 0.94% |
| Market Cap | $ 13.5m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -11.6m |
| Margin | 193221.20% |
MEI Pharma, Inc., an advanced stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San Diego, California.